← FDA Drug Approvals (Drugs@FDA)

DAPTOMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: QILU PHARM HAINAN · Approved 2021-08-24

Drug application

FDA Application #

ANDA215316

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPTOMYCIN

Generic name

DAPTOMYCIN

Active ingredients

DAPTOMYCIN

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

QILU PHARM HAINAN

Manufacturer

APOTEX CORP.

First approval

2021-08-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown